One- and Two-Year Multidisciplinary Follow-Up of MIS-C at a Tertiary Hospital: A Retrospective Cohort Study.

Sarah May JohnsonJustin PennerRichard IssittLaura KmenttKarlie GrantAshwin PandeyDimitrios ChampsasOmar Abdel-MannanSue MaillardKim McKenzieEmily GoldingFilip KuceraYael HacohenKaryn Moshal

Published in: The Pediatric infectious disease journal (2024)

Patients with MIS-C have a sustained recovery, which is reassuring for positive long-term outcomes. Across waves, time from symptom onset to diagnosis and treatment, symptomatology and length of stay were similar. Sustained recovery is reassuring for clinicians and parents alike. Differentiating long-COVID symptomatology from that of MIS-C is important in formulating an individualized treatment plan.

Keyphrases

coronavirus disease
sars cov
palliative care
quality improvement
magnetic resonance
computed tomography
contrast enhanced
replacement therapy